Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Renovacor Inc
(NY:
RCOR
)
N/A
UNCHANGED
Last Price
Updated: 8:00 PM EST, Nov 30, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Renovacor Inc
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress
October 10, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference
September 26, 2022
From
Renovacor, Inc.
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EVOP, STOR, RCKT, RCOR
September 22, 2022
Via
ACCESSWIRE
RCOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Renovacor, Inc. Is Fair to Shareholders
September 20, 2022
From
Halper Sadeh LLC
Via
Business Wire
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
September 20, 2022
From
Rocket Pharmaceuticals, Inc. and Renovacor, Inc.
Via
Business Wire
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 08, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy
July 12, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research
June 01, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 12, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer
March 28, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
March 24, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor to Participate in a Panel Presentation at the 11th Annual LifeSci Partners Corporate Access Event
January 03, 2022
From
Renovacor, Inc.
Via
Business Wire
Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 15, 2021
From
Renovacor, Inc.
Via
Business Wire
Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations
October 04, 2021
From
Renovacor, Inc.
Via
Business Wire
Renovacor to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
September 28, 2021
From
Renovacor, Inc.
Via
Business Wire
Renovacor Announces the Appointment of Jordan Shin, M.D., Ph.D., as Senior Vice President of Clinical Development and Translational Science
September 22, 2021
From
Renovacor, Inc.
Via
Business Wire
Renovacor to Present at the 2021 Virtual Wells Fargo Healthcare Conference
September 07, 2021
From
Renovacor, Inc.
Via
Business Wire
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
September 02, 2021
From
Renovacor, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.